Mayne Pharma reports H1 FY26 margin growth
Mayne Pharma (ASX:MYX) reported revenue of $212.1 million for the first half of FY26, a marginal 0.5% decrease compared to the previous corresponding period.
Every story in this category, newest first.
Mayne Pharma (ASX:MYX) reported revenue of $212.1 million for the first half of FY26, a marginal 0.5% decrease compared to the previous corresponding period.
Aussie Broadband's (ASX:ABB) H1 FY26 performance was headlined by a group revenue of $637.8 million, an 8.4% increase year over year.
Perenti (ASX:PRN) delivered its financial performance for the first half of 2026, maintaining momentum from its record-breaking 2025 results.
Ampol (ASX:ALD) reported a replacement cost operating profit EBITDA of $1.44 billion for H1 FY26, representing a 20% increase over the previous year.
Nuix (ASX:NXL) announced its financial results for the half-year ended Dec. 31, 2025, headlined by gains in annual contract value and a successful shift toward its modern platform.
Lendlease (ASX:LLC) reported a statutory loss of $318 million for the first half of the fiscal year, a sharp reversal from the $48 million profit recorded the prior year.
For the six months ended Dec. 31, 2025, Austal (ASX:ASB) reported revenue of $1.1 billion, a 34.4% increase a year ago.
Fisher & Paykel Healthcare (ASX:FPH) has upgraded its revenue and earnings guidance for the 2026 financial year ending March 31.
Reece (ASX:REH) recorded a downturn in profitability for the first half of the 2026 fiscal year, despite a modest lift in top-line revenue.
nib Group (ASX:NHF) reported its financial performance for the first half of 2026, headlined by a 22% rise in underlying operating profit, which reached $129.1 million.
The Australian sharemarket is facing a turbulent Feb. 23 opening after US President Donald Trump bypassed a US Supreme Court setback to impose a 15% universal tariff on all imports.
Sony CEO Hiroki Totoki speaks to David Westin on Wall Street Week about the company's funding options for its acquisition plans.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy